May 11, 2020 / 12:50 PM / 13 days ago

BRIEF-Tracon Pharmaceuticals Announces Successful Type B Meeting With FDA For Pivotal Study Of Envafolimab In Sarcoma

TRACON Pharmaceuticals Inc:

* TRACON PHARMACEUTICALS ANNOUNCES SUCCESSFUL TYPE B MEETING WITH FDA FOR PIVOTAL STUDY OF ENVAFOLIMAB IN SARCOMA

* TRACON PHARMACEUTICALS INC - EXPECTS TO INITIATE ENROLLMENT IN ENVASARC TRIAL IN SECOND HALF OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below